15.02.2017
- French pharmaceutical producer Sanofi has agreed to sell five consumer healthcare products in certain European territories to compatriot drugmaker Ipsen for €83 million. The cash...
27.01.2017
- Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...
11.01.2017
- French drugmaker Sanofi and US marketing partner Regeneron have announced they will appeal a ruling by a US federal district court judge that would prevent them from selling their...
05.01.2017
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have completed their business swap, which sees Sanofi take Boehringer’s consumer healthcare (CHC)...
04.01.2017
- Sanofi Pasteur, the global vaccines business unit of French drugmaker Sanofi, and Merck, Sharp and Dohme, international arm of US drugmaker Merck. have ended their vaccine joint...
03.01.2017
- An experimental Ebola vaccine initially developed by the Public Health Agency of Canada and the US Army and eventually licensed to Merck, Sharp and Dohme, the international arm of...
29.12.2016
- US healthcare company Johnson & Johnson (J&J) is negotiating a deal to acquire Actelion that would see its commercial portfolio separated from its R&D assets, according to news...
22.12.2016
- After US healthcare company Johnson & Johnson bowed out of the race to strike a deal with Swiss biotech-pharmaceuticals company Actelion, and Sanofi was reported to have launched...
15.12.2016
- Johnson & Johnson has withdrawn from the running for Actelion Pharmaceuticals, leaving the path clear for another buyer, which multiple reports say is Sanofi. The US healthcare...
15.12.2016
- Drugmaker Sanofi is facing a class action suit brought by French parents who allege their children suffered birth defects because their mothers took the company’s anticonvulsant...
